Binding of amyloid beta-protein to intracellular brain proteins in rat and human

Neurochemical Research

Volumn 23, Issue 10, 1998, Pages 1277-1282

  Ray, I ^a   Chauhan, A ^a   Wisniewski, H M ^a   Wegiel, J ^a   Kim, K S ^a   Chauhan, V P S ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

A binding proteins; Alzheimer's disease; Amyloid beta protein; Intracellular brain proteins

Indexed keywords

AMYLOID BETA PROTEIN; BINDING PROTEIN; BRAIN PROTEIN; CELL PROTEIN;

ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; BINDING SITE; BRAIN CORTEX; CONTROLLED STUDY; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; BRAIN; CASE-CONTROL STUDIES; HUMANS; MALONDIALDEHYDE; NERVE TISSUE PROTEINS; PEPTIDE FRAGMENTS; PROTEIN BINDING; RATS;

ANIMALIA;

EID: 0031791135     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020744216699     Document Type: Article

References (30)

1. Glenner, G. G. 1983. Alzheimer's disease: the commonest form of amyloidosis, Arch. Pathol. Lab. Med. 107:281-282.
2. Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., and Beyreuther, K. 1985. Amyloid plaque core protein in Alzheimer's disease and Down's Syndrome, Proc. Natl. Acad. Sci. U.S.A. 82:4245-4249.
3. Soto, C., Barnes, M. C., Avarez, J., and Inestrosa, N.C. 1994. Structural determinants of the Alzheimer's amyloid β-protein, J. Neurochem. 63:1191-1198.
4. Yankner, B. A., Duffy, L. K., and Kirschner, D.A. 1990. Neurotrophic and neurotoxic effects of β-protein: reversal by tachykinin neuropeptide, Science 250:279-282.
5. Pike, C. J., Walencewicz, J., Glabe, C. G., and Cotman, C.W. 1991. In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity, Brain Res. 563:311-314.
6. Iversen, L. L., Mortishire-Smith, R. J., Pollack, S. J., and Shearman, M. S. 1995. The toxicity in vitro of β-amyloid protein, Biochem. J. 311:1-16.
7. Kar S., Soto, D., Gaudreau, P., and Quirion, R. 1996. Beta-amyloid-related peptides inhibit potassium-evoked acetylcholine release from rat hippocampal slices, J. Neurosci. 16:1034-40.
8. Chauhan, A., Chauhan, V. P. S., Singh, S. S., Brockerhoff, H., and Wisniewski, H. M. 1995 Stimulation of phosphatidylinositol 3-kinase activity by Alzheimer's amyloid beta-protein, J. Neurochem. 65:S45.
9. Chauhan, A., Chauhan, V. P. S., Brockerhoff, H., and Wisniewski, H. M. 1991. Action of amyloid beta-protein on protein kinase C activity, Life Sci. 49:1555-1562.
10. Hogan, M., Pawloska, Z., Yang, H. A., Kornecki, E., and Ehrlich, Y. 1995. Surface phosphorylation by ecto-protein kinase C in brain neurons: a target for Alzheimer's β-amyloid peptides, J. Neurochem. 65:2022-30.
11. Chauhan, A., Chauhan, V. P. S., Murakami, N., Brockerhoff, H., and Wisniewski, H. M. 1993. Amyloid β-protein stimulates casein kinase I and casein kinase II, Brain Res. 629:47-52.
12. Koudinov, A., Matsubara, E, Frangione, B., and Ghiso, J. 1994. The soluble form of Alzheimer's amyloid beta-protein is complexed to high-density lipoprotein 3 and very high density lipoprotein in normal human plasma, Biochem. Biophys. Res. Commun. 205:1164-1171.
13. Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L.-M., Salvesen, G. S., Pericak-Vance M., Schmechel, D., Saunders, A. M., Goldgaber, D., and Roses, A. D. 1993. Binding of human apolipoprotein E to synthetic amyloid β-peptide: isoform-specific effects and implications for late-onset Alzheimer's disease, Proc. Natl. Acad. Sci. U.S.A. 90:1977-1981.
14. Ghiso, J., Matsubara, E., Koudinov. A., Choi-Miura, N. H., Tomita, M., Wisniewski, T., and Frangione, B. 1993. The cerebrospinal fluid soluble form of Alzheimer's amyloid β is complexed to SP-40, 40 (Apo J), an inhibitor of the complement membrane attack complex, Biochem. J. 293:27-30.
15. Schwarzman, A. L., Gregori, L., Vitek, M. P., Lyubski, S., Strittmatter, W. J., Enghilde, J.J., Bhasin, R., Silverman, J., Weisgraber, K. H., Coyle, P. K., Zagorski, M. G., Talafous, J., Eisenberg, M., Saunders, A. M., Rose, A. D., and Goldgaber, D. 1994. Transthyretin sequesters amyloid β-protein and prevents amyloid formation, Proc. Natl. Acad. Sci. U.S.A. 91:8368-8371.
16. Kim, K. S., Miller, D. L., Sapienza, V. J., Chen, C. M. J., Bai, C., Grundke-Iqbal, I., Currie, J. R., and Wisniewski, H. M. 1988. Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide, Neurosci. Res. Commun. 2:121-130.
17. Kim, K. S., Wen, G. Y., Bancher, C., Chen, C. M. J., Hong, H., and Wisniewski, H. M. 1990. Detection and quantitation of amyloid β-peptide with 2 monoclonal antibodies, Neurosci. Res. Commun. 7:113-122.
18. Bradford, M. A. 1976. A rapid and sensitive method for the quantitation of microgram quantities of proteins utilizing the principle of protein-dye binding, Anal. Biochem. 72:248-254.
19. Chauhan, V. P. S., Ray, I., Chauhan, A., Wegiel, J., and Wisniewski, H.M. 1997. Metal cations defibrillize the amyloid beta-protein fibrils, Neurochem. Res. 22:805-809.
20. Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., Yates, J., Cotman, C., and Glabe, C. 1992. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptides analogs, J. Biol. Chem. 267:546-554.
21. 2 can traverse liposomal bilayers, Life Sci. 35:1395-1399.
22. 1-antichymotrypsin binding to Alzheimer Aβ peptides is sequence specific and induces fibril disaggregation in vitro, J. Neurochem. 61:298-305.
23. Selkoe, D. J. 1991. The molecular pathology of Alzheimer's disease, Neuron 6:487-498.
24. Hilbich, C., Kisters-Woike, B., Reed, J., Masters, C. L., and Beyreuther, K., 1991. Human and rodent sequence analogs of Alzheimer's amyloid beta A4 share similar properties and can be solubilized in buffers of pH 7.4, Eur. J. Biochem. 201:61-69.
25. Turner, R. S., Suzuki, N., Chyung, A., Younkin, S. G., and Lee, V. 1996. Amyloid β40 and β42 are generated intracellularly in cultured human neurons and their secretion increases with maturation, J. Biol. Chem. 271:8966-8970.
26. Harman, D. 1992. Role of free radicals in aging and disease, Ann. N.Y. Acad. Sci. 673:126-41.
27. Thomas, T., Thomas, G., McLendon, C. Sutton, T., and Mullan, M. 1996. Beta-amyloid-mediated vasoactivity and vascular endothelial damage, Nature 380:168-171.
28. Behl, C., Davis, J. B., Lesley, R., and Schubert, P. 1994. Hydrogen peroxide mediates amyloid beta protein toxicity, Cell 77:817-827.
29. Yan, S. D., Fu, J., Soto, C., Chen, X., Zhu, H., Al-Mohanna, F., Collison, K., Zhu, A., Stem, E., Saido, T., Tohyama, M., Ogawa, S., Roher, A., and Stern, D. 1997. An intracellular protein that binds to amyloid β-peptide and mediates neurotoxicity in Alzheimer's disease, Nature 389:689-695.
30. Chauhan, A., Chauhan, V. P. S., Brockerhoff, H., and Wisniewski, H. M. 1993. Effect of amyloid beta-protein on membrane properties. in (B. Corain, K. Iqbal, M. Nicolini, B. Winblad, H. Wisniewski and P. Zatta, (eds.), Alzheimer's disease: Advances in Clinical and Basic Research. John Wiley & Sons Ltd, p. 431-439.